Geval – a complete solution

Innovative Genomics & Microbiome Solutions for Precision Health

Affordable, scalable, and precise genomic & microbiome solutions for personalized medicine

Explore Our Solutions Partner With Us
Geval – a complete solution

Innovative Genomics & Microbiome Solutions for Precision Health

Affordable, scalable, and precise genomic & microbiome solutions for personalized medicine.

Explore Our Solutions Partner With Us

DNA Testing

Accurate genomic analysis that assesses genetic disease risks using comprehensive genome sequencing.

Gut Microbiome

Personalized diagnostics and nutrition insights based on your unique gut microbiome profile.

AI Analytics

Powered by the GeneReveal AI platform, rated by EMQN for precision analytics.

Scalable Screening

Designed for affordable population-wide screening and large-scale clinical deployment.

geval-cover
Reason to choose us

What Sets Us Apart

Geval integrates advanced genomics, microbiome science, and AI-driven analytics to deliver precision health insights that are accurate, affordable, and clinically actionable.

Polygenic Risk Scores

Long-Read Sequencing

Population-Specific Panels

Microbiome Integration

Personalized Nutrition

Affordable & Scalable

Key Benefits

We also provide

Cost-effective

Holistic insights

Scalable population screening

what We Provide

Products & Services

Low-coverage sequencing

Comprehensive genome scanning with cost-optimized, low-coverage whole-genome sequencing to detect disease-associated variants.

Long-read sequencing

Advanced sequencing that captures structural changes and complex genomic features.

Cancer risk genetic reports

Population-calibrated risk reports for breast, prostate, and other cancers using polygenic risk scoring.

Microbiome-based diagnostics

Insights into gut microbial patterns linked with colorectal cancer and metabolic health.

GeneReveal AI-powered platform (Scored highest possible rating by EMQN)

Clinical analytics platform integrating genomic and microbiome data for actionable insights.

Success stories

We tell our stories through our works

We have parters all around the world. We are always open to collaboration in the healthcare, genomics and related R & D

  • Case Study: Singapore Changi hospital Lp(a) PRS Project

    Geval partnered with clinical teams to deploy population-specific polygenic risk models to predict Lp(a) levels in blood.

  • Case Study: Customized state-of-the-art analysis pipeline

    Geval partnered with Next Level Genomics in Singapore to develop an accurate pipeline for copy number variations (CNVs) involving large repeats in long-read data.

Our trusted partners and valuable clients

FAQ

A Polygenic Risk Score (PRS) estimates an individual’s inherited risk for complex diseases by analyzing thousands to millions of genetic variants across the genome. Unlike single-gene tests, PRS captures cumulative genetic effects and can identify elevated disease risk years before symptoms appear.

Geval combines low-coverage whole-genome sequencing, long-read sequencing, population-specific reference panels, and gut microbiome analysis into a single platform. This integrated approach improves accuracy for diverse populations while remaining cost-effective and scalable for clinical use.

Geval solutions support risk assessment for complex diseases including breast cancer, prostate cancer, cardiovascular disease, type 2 diabetes, colorectal cancer, and metabolic disorders.

Most global genetic risk models are based on European populations, which can reduce accuracy for other ancestries. Geval develops population-calibrated models to improve risk prediction and clinical relevance for underrepresented populations.

The gut microbiome plays a key role in digestion, metabolism, immunity, and cancer risk. Geval analyzes microbial DNA from stool samples to identify patterns associated with colorectal cancer and metabolic disorders, enabling personalized prevention strategies.

Yes. By using low-coverage sequencing and advanced imputation methods, Geval delivers clinically meaningful insights at a significantly lower cost than traditional high-coverage genome sequencing.

Geval is designed for clinical integration and supports pilot programs, clinician training, and joint research initiatives with hospitals and academic institutions.

Join us in revolutionizing precision medicine

Explore Our Solutions Partner With Us